View in EDS

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.
Authors: Simonelli, M.1 matteo.simonelli@cancercenter.humanitas.it, Zucali, P.1, Santoro, A.1, Thomas, M. B.2, de Braud, F. G.3, Borghaei, H.4, Berlin, J.5, Denlinger, C. S.4, Noberasco, C.3, Rimassa, L.1, Kim, T.-Y.6, English, P. A.7, Abbattista, A.8, Stampino, C. Gallo8, Carpentieri, M.8, Williams, J. A.7
Source: Annals of Oncology. Sep2016, Vol. 27 Issue 9, p1782-1787. 6p. 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdw240